Reuters - Prosecutors are seeking about $1 billion to resolve a long-standing probe into Johnson & Johnson's marketing of its Risperdal anti-psychotic medicine, the Wall Street Journal said on Thursday, citing sources familiar with the matter.
You are here:
Health 
Medications & Drugs U.S. seeking $1 billion from J&J in Risperdal probe: report
(Reuters)
Medications & Drugs U.S. seeking $1 billion from J&J in Risperdal probe: report
(Reuters)
